Calithera Biosciences, Inc. is a clinical stage precision oncology biopharmaceutical company, which engages in developing targeted therapies to redefine treatment for biomarker-specific patient populations. The company is headquartered in South San Francisco, California and currently employs 8 full-time employees. The company went IPO on 2014-10-02. The firm is winding up its operations. The firm is seeking to sell all of its clinical assets and programs. The firm has not generated any revenue.
Follow-Up Questions
What is Calithera Biosciences Inc (CALA)'s P/E Ratio?
The P/E ratio of Calithera Biosciences Inc is 0
Who is the CEO of Calithera Biosciences Inc?
Dr. Susan Molineaux is the President of Calithera Biosciences Inc, joining the firm since 2010.
What is the price performance of CALA stock?
The current price of CALA is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Calithera Biosciences Inc?
Calithera Biosciences Inc belongs to Biotechnology industry and the sector is Health Care
What is Calithera Biosciences Inc market cap?
Calithera Biosciences Inc's current market cap is $487
Is Calithera Biosciences Inc a buy, sell, or hold?
According to wall street analysts, 4 analysts have made analyst ratings for Calithera Biosciences Inc, including 0 strong buy, 0 buy, 3 hold, 1 sell, and 0 strong sell
